Search alternatives:
point decrease » point increase (Expand Search)
non decrease » note decreased (Expand Search), fold decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
non decrease » note decreased (Expand Search), fold decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
17001
Data_Sheet_1_MiR-30c-5p/ATG5 Axis Regulates the Progression of Parkinson’s Disease.xlsx
Published 2021“…MiR-30c-5p antagomiR attenuated the decrease of ATG5 in PD mice. …”
-
17002
-
17003
-
17004
Table_1_A Novel Strategy to Coat Dopamine-Functionalized Titanium Surfaces With Agarose-Based Hydrogels for the Controlled Release of Gentamicin.docx
Published 2021“…</p>Results<p>A homogeneous coating was obtained with all the hydrogel formulations. …”
-
17005
-
17006
-
17007
-
17008
-
17009
-
17010
Image_5_Extensive Healthy Donor Age/Gender Adjustments and Propensity Score Matching Reveal Physiology of Multiple Sclerosis Through Immunophenotyping.tif
Published 2020“…</p><p>The goals of this blinded training and validation study of MS patients and embedded controls, representing 1,240 prospectively acquired paired CSF/blood samples from 588 subjects was (1) to define physiological age-/gender-related changes in CSF cells, (2) to define/validate cellular abnormalities in blood and CSF of untreated MS through disease duration (DD) and determine which are MS-specific, and (3) to compare effect(s) of low-efficacy (i.e., interferon-beta [IFN-beta] and glatiramer acetate [GA]) and high-efficacy drugs (i.e., natalizumab, daclizumab, and ocrelizumab) on MS-related cellular abnormalities using propensity score matching.…”
-
17011
-
17012
-
17013
-
17014
-
17015
-
17016
Dose- and time-dependent response of <i>M</i>. <i>aeruginosa</i> fluorescence to H<sub>2</sub>O<sub>2</sub> exposure.
Published 2023“…In contrast, the percentage of cells treated with low dose (7.5 μg/mL) H<sub>2</sub>O<sub>2</sub> found in the control region decreased each day and remained around 30% on day 8.…”
-
17017
-
17018
-
17019
-
17020